220 related articles for article (PubMed ID: 24119290)
21. Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease.
Tang X; Chen M; Zhang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 38(6):553-9. PubMed ID: 23828708
[TBL] [Abstract][Full Text] [Related]
22. The association between serum hepcidin-25 level and subclinical atherosclerosis in peritoneal dialysis patients.
Erdoğan B; Eser B; Yayar Ö; Aylı MD
Turk Kardiyol Dern Ars; 2018 Mar; 46(2):121-128. PubMed ID: 29512612
[TBL] [Abstract][Full Text] [Related]
23. Correlates of habitual physical activity in chronic haemodialysis patients.
Zamojska S; Szklarek M; Niewodniczy M; Nowicki M
Nephrol Dial Transplant; 2006 May; 21(5):1323-7. PubMed ID: 16421165
[TBL] [Abstract][Full Text] [Related]
24. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation.
Rodrigues AS; Almeida M; Fonseca I; Martins M; Carvalho MJ; Silva F; Correia C; Santos MJ; Cabrita A
Nephrol Dial Transplant; 2006 Mar; 21(3):763-9. PubMed ID: 16332703
[TBL] [Abstract][Full Text] [Related]
25. Serum fetuin-A levels, QT dispersion and P dispersion in dialysis patients.
Taskapan MC; Taskapan H; Comert M; Temel I; Yagmur J; Ulutas O
Ren Fail; 2013; 35(4):477-82. PubMed ID: 23438291
[TBL] [Abstract][Full Text] [Related]
26. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
[TBL] [Abstract][Full Text] [Related]
27. Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation.
Xu Y; Ding XQ; Zou JZ; Liu ZH; Jiang SH; Chen YM
J Int Med Res; 2011; 39(5):1961-7. PubMed ID: 22118000
[TBL] [Abstract][Full Text] [Related]
28. Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients.
Oh KH; Moon JY; Oh J; Kim SG; Hwang YH; Kim S; Lee JS; Ahn C
Nephrol Dial Transplant; 2008 Jul; 23(7):2356-64. PubMed ID: 18178604
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients.
Shioya M; Yoshida T; Kasai K; Furuya R; Kato A; Mori N; Matsumoto Y; Kumagai H
Nephrology (Carlton); 2013 Aug; 18(8):539-44. PubMed ID: 23718260
[TBL] [Abstract][Full Text] [Related]
30. Influence of Residual Renal Function in Carotid Modeling as a Marker of Early Atherosclerosis in Dialysis Patients.
Rroji M; Spahia N; Seferi S; Barbullushi M; Spasovski G
Ther Apher Dial; 2017 Oct; 21(5):451-458. PubMed ID: 28714271
[TBL] [Abstract][Full Text] [Related]
31. Effect of hepatitis C virus on C-reactive protein and interleukin-6 in hemodialysis patients.
Afzal N; Abbas S; Ahmed A; Arif M; Javeed K
Iran J Kidney Dis; 2011 Jul; 5(3):182-6. PubMed ID: 21525578
[TBL] [Abstract][Full Text] [Related]
32. Association of Hepcidin With Anemia Parameters in Incident Dialysis Patients: Differences Between Dialysis Modalities.
Lim JH; Park YW; Lee SH; Do JY; Kim SH; Han S; Jung HY; Choi JY; Cho JH; Kim CD; Park SH; Kim YL
Ther Apher Dial; 2020 Feb; 24(1):4-16. PubMed ID: 31090188
[TBL] [Abstract][Full Text] [Related]
33. Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin.
Malyszko J; Malyszko JS; Kozminski P; Mysliwiec M
Ren Fail; 2009; 31(10):876-83. PubMed ID: 20030521
[TBL] [Abstract][Full Text] [Related]
34. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.
Stompór T; Pasowicz M; Sulłowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tracz W; Zdzienicka A; Klimeczek P; Janusz-Grzybowska E
Am J Kidney Dis; 2003 Jan; 41(1):203-11. PubMed ID: 12500238
[TBL] [Abstract][Full Text] [Related]
35. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Hepcidin and Atherosclerosis in Dialysis Patients.
Manolov V; Petrova J; Bogov B; Hadjidekova S; Vasilev V; Yonova D; Petrova M; Kunchev T; Jelev Y; Jeliazkov P; Marinov B; Bogov I; Gramatikova Z; Voleva S; Tzatchev K; Traykov L
Clin Lab; 2017 Nov; 63(11):1787-1792. PubMed ID: 29226654
[TBL] [Abstract][Full Text] [Related]
37. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease.
Tandara L; Grubisic TZ; Ivan G; Jurisic Z; Tandara M; Gugo K; Mladinov S; Salamunic I
Clin Biochem; 2015 Dec; 48(18):1252-7. PubMed ID: 26164540
[TBL] [Abstract][Full Text] [Related]
38. Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity.
Andrews M; Soto N; Arredondo-Olguín M
Nutrition; 2015 Jan; 31(1):51-7. PubMed ID: 25441587
[TBL] [Abstract][Full Text] [Related]
39. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis.
Samouilidou EC; Grapsa E
Ren Fail; 2008; 30(7):711-5. PubMed ID: 18704820
[TBL] [Abstract][Full Text] [Related]
40. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
